{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T17:01:19Z","timestamp":1780938079171,"version":"3.54.1"},"reference-count":54,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T00:00:00Z","timestamp":1780876800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Journal of Medical Economics"],"published-print":{"date-parts":[[2026,12,31]]},"DOI":"10.1080\/13696998.2026.2682692","type":"journal-article","created":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T16:31:43Z","timestamp":1780936303000},"page":"1632-1648","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Economic evaluation of a bivalent respiratory syncytial virus prefusion F vaccine for maternal vaccination in Sweden: cost-effectiveness and budget impact"],"prefix":"10.1080","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9291-0559","authenticated-orcid":false,"given":"M\u00e1t\u00e9","family":"Szilcz","sequence":"first","affiliation":[{"name":"Viti Science AB","place":["Stockholm, Sweden"]},{"name":"Department of Medical Epidemiology and Biostatistics, Karolinska Institutet","place":["Stockholm, Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parissa","family":"Naghipour","sequence":"additional","affiliation":[{"name":"Viti Science AB","place":["Stockholm, Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann-Charlotte","family":"Fridh","sequence":"additional","affiliation":[{"name":"Access and Value, Pfizer AB","place":["Stockholm, Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherina","family":"Zakikhany-Gilg","sequence":"additional","affiliation":[{"name":"Medical and Scientific Affairs, Pfizer AB","place":["Stockholm, Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Palmborg","sequence":"additional","affiliation":[{"name":"Medical and Scientific Affairs, Pfizer AB","place":["Stockholm, Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samira","family":"Toghanian","sequence":"additional","affiliation":[{"name":"Access and Value, Pfizer AB","place":["Stockholm, Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,6,8]]},"reference":[{"key":"e_1_3_7_2_1","unstructured":"Swedish Medical Products Agency.; 2025. Treatment recommendation: respiratory syncytial virus (RSV) infection."},{"key":"e_1_3_7_3_1","unstructured":"Public Health Agency of Sweden. Vaccination mot RS-virus 2025. Available from: https:\/\/www.folkhalsomyndigheten.se\/smittskydd-beredskap\/vaccinationer\/vacciner-som-anvands-i-sverige\/vaccin-mot-rs-virus\/#:\u223c:text=RSV%2Dvaccination%20rekommenderas%20till%20personer ocks%C3%A5%20vaccination%20mot%20RS%2Dvirus."},{"key":"e_1_3_7_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2025.101447"},{"key":"e_1_3_7_5_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiz683"},{"key":"e_1_3_7_6_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-021-06399-8"},{"key":"e_1_3_7_7_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-024-09975-w"},{"key":"e_1_3_7_8_1","doi-asserted-by":"publisher","DOI":"10.1007\/s15010-024-02391-x"},{"key":"e_1_3_7_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/irv.13211"},{"key":"e_1_3_7_10_1","doi-asserted-by":"publisher","DOI":"10.3390\/diseases11040126"},{"key":"e_1_3_7_11_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00431-025-06460-7"},{"key":"e_1_3_7_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-4642(22)00321-2"},{"key":"e_1_3_7_13_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2216480"},{"key":"e_1_3_7_14_1","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000005816"},{"key":"e_1_3_7_15_1","unstructured":"European Medicines Agency. Abrysvo. ; 2023."},{"key":"e_1_3_7_16_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7241e1"},{"key":"e_1_3_7_17_1","unstructured":"European Medicines Agency. Beyfortus; 2022."},{"key":"e_1_3_7_18_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40121-024-00975-6"},{"key":"e_1_3_7_19_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40121-024-01000-6"},{"key":"e_1_3_7_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2023.100829"},{"key":"e_1_3_7_21_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40121-024-01055-5"},{"key":"e_1_3_7_22_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2024-066481"},{"key":"e_1_3_7_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lana.2023.100629"},{"key":"e_1_3_7_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2025.127191"},{"key":"e_1_3_7_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2023.01.058"},{"key":"e_1_3_7_26_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2025.2521912"},{"key":"e_1_3_7_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/irv.70161"},{"key":"e_1_3_7_28_1","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2025.2562201"},{"key":"e_1_3_7_29_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines13010077"},{"key":"e_1_3_7_30_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2025-071558"},{"key":"e_1_3_7_31_1","unstructured":"Statens Serum Institut. ; 2025. No 38-2025: free RSV vaccination for pregnant women from October 1 2025."},{"key":"e_1_3_7_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-4642(25)00155-5"},{"key":"e_1_3_7_33_1","doi-asserted-by":"publisher","DOI":"10.1080\/23744235.2025.2580945"},{"key":"e_1_3_7_34_1","unstructured":"Finnish Institute for Health and Welfare. RSV. 2026. Available from: https:\/\/thl.fi\/sv\/teman\/infektionssjukdomar-och-vaccinationer\/sjukdomar-och-bekampning\/sjukdomar-och-sjukdomsalstrare-a-o\/rsv."},{"key":"e_1_3_7_35_1","unstructured":"Dookhun D et al. PD056 \u2013 Impact of a mixed strategy of monoclonal antibody and maternal immunization on pediatric RSV hospitalizations in Luxembourg 2022\u20132024 ESPID2025. 2025."},{"key":"e_1_3_7_36_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10654-025-01226-9"},{"key":"e_1_3_7_37_1","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000005113"},{"key":"e_1_3_7_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2013.11.013"},{"key":"e_1_3_7_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2019.10.023"},{"key":"e_1_3_7_40_1","unstructured":"Sp\u00e4dbarnsd\u00f6dlighet efter k\u00f6n. 2024. \u00c5r 1946-2024 [Internet]. Available from: https:\/\/www.statistikdatabasen.scb.se\/pxweb\/sv\/ssd\/START__BE__BE0101__BE0101I\/Spadbarnsdodlighet\/."},{"key":"e_1_3_7_41_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciae596"},{"key":"e_1_3_7_42_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1651-2227.2011.02309.x"},{"key":"e_1_3_7_43_1","unstructured":"NT r\u00e5det Samverkan l\u00e4kemedel. Beyfortus (nirsevimab) f\u00f6r prevention av sjukdom orsakad av respiratoriskt syncytialvirus (RSV); 2026."},{"key":"e_1_3_7_44_1","unstructured":"Roy LMC. Deriving health utility weights for infants with respiratory syncytial virus (RSV) [Text]; 2013."},{"key":"e_1_3_7_45_1","doi-asserted-by":"publisher","DOI":"10.1111\/irv.12686"},{"key":"e_1_3_7_46_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2024-066461"},{"key":"e_1_3_7_47_1","doi-asserted-by":"publisher","DOI":"10.1111\/apa.16046"},{"key":"e_1_3_7_48_1","unstructured":"Statems Serum Institut. ; 2026. EPI-NYT Uge 5 [Accessed 2026-04-10]."},{"key":"e_1_3_7_49_1","volume-title":"5P. 081. Effectiveness of a mixed maternal and passive infant immunisation strategy to prevent RSV-related paediatric hospitalisations in Luxembourg","author":"Ernst C.","year":"2025","unstructured":"Ernst, C., Dookhun, D., Del Lero, N., et al., editors. 5P. 081. Effectiveness of a mixed maternal and passive infant immunisation strategy to prevent RSV-related paediatric hospitalisations in Luxembourg. Vienna: ESCMID Global; 2025."},{"key":"e_1_3_7_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2024.126541"},{"key":"e_1_3_7_51_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.60735"},{"key":"e_1_3_7_52_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2019-3611"},{"key":"e_1_3_7_53_1","unstructured":"S\u00f6dra sjukv\u00e5rdsregionen. Regionala priser och ers\u00e4ttningar f\u00f6r s\u00f6dra sjukv\u00e5rdsregionen; 2026."},{"key":"e_1_3_7_54_1","unstructured":"Statistics Sweden. F\u00f6dda och d\u00f6da per m\u00e5nad efter k\u00f6n. \u00c5r 1851-2024; 2024."},{"key":"e_1_3_7_55_1","unstructured":"Barnl\u00e4karf\u00f6reningen. \u00c5rsrapport; 2024."}],"container-title":["Journal of Medical Economics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13696998.2026.2682692","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T16:31:52Z","timestamp":1780936312000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/13696998.2026.2682692"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,8]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12,31]]}},"alternative-id":["10.1080\/13696998.2026.2682692"],"URL":"https:\/\/doi.org\/10.1080\/13696998.2026.2682692","relation":{},"ISSN":["1369-6998","1941-837X"],"issn-type":[{"value":"1369-6998","type":"print"},{"value":"1941-837X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,8]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijme20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijme20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2026-04-24","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-27","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-27","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-08","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}